Institutional Fund
Stonepine Capital Management, LLC
Bend, ORCIK 14407715 filings on record
Portfolio Value
$113.69M
Q1 2026
Holdings
66
Reported positions
New Buys
20
Opened this quarter
QoQ Change
-10.1%
from $126.43M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Verastem Inc15.4%
- Tenax Therapeutics Inc13.7%
- Evolus Inc6.4%
- Adma Biologics Inc5.9%
- Camp4 Therapeutics Corp5.4%
- Nektar Therapeutics5.4%
- Other47.9%
Portfolio Holdings
66 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Verastem Inc | 3.30M | $17.50M | 15.4% | +570.2K | Added |
| 2 | Tenax Therapeutics Inc | 975.2K | $15.59M | 13.7% | +963.3K | Added |
| 3 | Evolus Inc | 1.76M | $7.23M | 6.4% | +127.5K | Added |
| 4 | Adma Biologics Inc | 740.0K | $6.67M | 5.9% | 0 | Held |
| 5 | Camp4 Therapeutics Corp | 1.39M | $6.13M | 5.4% | +1.16M | Added |
| 6 | Nektar Therapeutics | 85.0K | $6.12M | 5.4% | 0 | Held |
| 7 | Zevra Therapeutics Inc | 480.0K | $4.47M | 3.9% | −89.1K | Reduced |
| 8 | Corbus Pharmaceuticals Hldgs | 383.5K | $3.60M | 3.2% | −6.5K | Reduced |
| 9 | Abeona Therapeutics Inc | 746.6K | $3.34M | 2.9% | +37.1K | Added |
| 10 | Kazia Therapeutics Ltd | 345.2K | $2.57M | 2.3% | −115.2K | Reduced |
56 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio